{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifqyfj5aiydw3jyigq7y37xfe4ahesdy36g76dfrpbpwn2dg4yvum",
    "uri": "at://did:plc:izotgtw5czjnuqtpcldjnkjh/app.bsky.feed.post/3milkzhv3taw2"
  },
  "path": "/breakthrough-alzheimers-drug-rewires-the-brain-instead-of-just-clearing-plaques/",
  "publishedAt": "2026-04-03T10:36:47.000Z",
  "site": "https://scitechdaily.com",
  "tags": [
    "Health",
    "Alzheimer's Disease",
    "Brain",
    "Dementia",
    "Neurology",
    "University of Barcelona"
  ],
  "textContent": "An experimental drug is showing promise by targeting Alzheimer’s disease at the level of gene regulation. Researchers at the University of Barcelona have developed an experimental Alzheimer’s drug that aims at a very different target from today’s approved treatments. Instead of mainly clearing beta-amyloid plaques from the brain, the compound, called FLAV-27, is designed to [...]",
  "title": "Breakthrough Alzheimer’s Drug Rewires the Brain Instead of Just Clearing Plaques"
}